Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients
Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic an...
Saved in:
Main Authors: | Erica Cassani, Raffaella Cancello, Ferruccio Cavanna, Sabrina Maestrini, Anna Maria Di Blasio, Antonio Liuzzi, Gianni Pezzoli, Michela Barichella |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.4061/2011/624764 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum adiponectin levels in patients with rheumatoid arthritis
by: Ganesh Veluri, et al.
Published: (2019-01-01) -
Elevated Adiponectin Serum Levels in Women with Systemic Autoimmune Diseases
by: Éric Toussirot, et al.
Published: (2010-01-01) -
Alterations in Serum Adropin, Adiponectin, and Proinflammatory Cytokine Levels in OSAS
by: Hakan Celikhisar, et al.
Published: (2020-01-01) -
Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease
by: Margherita Canesi, et al.
Published: (2020-01-01) -
Serum Adiponectin Level in Diabetic Patients with and without Helicobacter pylori Infection: Is There Any Difference?
by: Jamshid Vafaeimanesh, et al.
Published: (2014-01-01)